New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 13, 2022 - Amneal announced the FDA approval of Alymsys (bevacizumab-maly), biosimilar to Genentech’s Avastin® (bevacizumab).
Download PDF
Return to publications
